| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |